1. Home
  2. ITRM vs DHAI Comparison

ITRM vs DHAI Comparison

Compare ITRM & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • DHAI
  • Stock Information
  • Founded
  • ITRM 2015
  • DHAI 2007
  • Country
  • ITRM Ireland
  • DHAI United States
  • Employees
  • ITRM N/A
  • DHAI N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • DHAI
  • Sector
  • ITRM Health Care
  • DHAI
  • Exchange
  • ITRM Nasdaq
  • DHAI NYSE
  • Market Cap
  • ITRM 49.5M
  • DHAI 49.1M
  • IPO Year
  • ITRM 2018
  • DHAI N/A
  • Fundamental
  • Price
  • ITRM $1.54
  • DHAI $1.23
  • Analyst Decision
  • ITRM Strong Buy
  • DHAI
  • Analyst Count
  • ITRM 1
  • DHAI 0
  • Target Price
  • ITRM $5.00
  • DHAI N/A
  • AVG Volume (30 Days)
  • ITRM 671.4K
  • DHAI 430.9K
  • Earning Date
  • ITRM 11-14-2024
  • DHAI 11-14-2024
  • Dividend Yield
  • ITRM N/A
  • DHAI N/A
  • EPS Growth
  • ITRM N/A
  • DHAI N/A
  • EPS
  • ITRM N/A
  • DHAI N/A
  • Revenue
  • ITRM N/A
  • DHAI $73,490,000.00
  • Revenue This Year
  • ITRM N/A
  • DHAI N/A
  • Revenue Next Year
  • ITRM N/A
  • DHAI N/A
  • P/E Ratio
  • ITRM N/A
  • DHAI N/A
  • Revenue Growth
  • ITRM N/A
  • DHAI 16.95
  • 52 Week Low
  • ITRM $0.81
  • DHAI $0.72
  • 52 Week High
  • ITRM $3.02
  • DHAI $3.67
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 39.39
  • DHAI 45.76
  • Support Level
  • ITRM $1.58
  • DHAI $1.22
  • Resistance Level
  • ITRM $2.10
  • DHAI $1.57
  • Average True Range (ATR)
  • ITRM 0.14
  • DHAI 0.33
  • MACD
  • ITRM -0.04
  • DHAI -0.05
  • Stochastic Oscillator
  • ITRM 11.11
  • DHAI 4.05

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About DHAI DIH HOLDINGS US INC

DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.

Share on Social Networks: